Abbvie Inc. officer Hudson Thomas J is set to sell 101,886 shares of the company's common stock, with an aggregate market value of approximately $19,115,379.79. The sale is scheduled for 08/07/2024, which coincides with the date Hudson acquired the shares through a stock option exercise as part of his compensation from the issuer. This transaction follows a period where no securities transactions were reported by Hudson in the past three months.

Abbvie Inc. officer Hudson Thomas J is set to sell 101,886 shares of the company's common stock, with an aggregate market value of approximately $19,115,379.79. The sale is scheduled for 08/07/2024, which coincides with the date Hudson acquired the shares through a stock option exercise as part of his compensation from the issuer. This transaction follows a period where no securities transactions were reported by Hudson in the past three months.